AMPHAmphastar Pharmaceuticals, ...

Nasdaq amphastar.com


$ 43.26 $ -0.09 (-0.21 %)    

Friday, 24-May-2024 15:59:46 EDT
QQQ $ 454.82 $ 4.29 (0.95 %)
DIA $ 398.57 $ -0.02 (-0.01 %)
SPY $ 530.36 $ 3.48 (0.66 %)
TLT $ 91.26 $ 0.27 (0.3 %)
GLD $ 225.37 $ 0.20 (0.09 %)
$ 43.26
$ 43.11
$ 0.00 x 0
$ 0.00 x 0
$ 42.93 - $ 43.70
$ 38.43 - $ 67.66
226,682
na
2.29B
$ 0.73
$ 14.83
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-26-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-amphastar-pharma

Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.

 amphastar-bags-fda-approval-for-albuterol-sulfate-inhalation-aerosol

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has gr...

 needham-reiterates-hold-on-amphastar-pharma

Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.

 amphastar-pharma-q1-2024-adj-eps-104-beats-077-estimate-sales-171800m-miss-174713m-estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.7...

 federal-trade-commission-targets-junk-patent-listings-for-diabetes-weight-loss-asthma-drugs-from-companies-like-novo-nordisk-astrazeneca

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, a...

 amphastar-pharmaceuticals-interested-in-potential-acquisitions-in-endocrinology-focused-companies

Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid...

 needham-reiterates-hold-on-amphastar-pharma

Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.

 jp-morgan-initiates-coverage-on-amphastar-pharma-with-overweight-rating-announces-price-target-of-60

JP Morgan analyst Ekaterina Knyazkova initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Overweight rating and anno...

 amphastar-pharma-q4-eps-088-misses-091-estimate-sales-17810m-beat-17567m-estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $0...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 jim-cramer-says-hold-onto-this-biotech-stock-i-dont-understand-why-its-so-inexpensive

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here.

 b-of-a-securities-initiates-coverage-on-amphastar-pharma-with-neutral-rating-announces-price-target-of-63

B of A Securities analyst Jason Gerberry initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Neutral rating and anno...

 disney-twilio-transdigm-marathon-digital-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording ga...

 amphastar-pharma-q3-adj-eps-115-beats-069-estimate-sales-18056m-beat-17463m-estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly Adj earnings of $1.15 per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-november-8-2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

 why-cs-disco-are-trading-lower-by-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION